Matthew Herper
23andMe enters biopharmaceutical business with Genentech deal
A deal being announced today with Genentech points the way for 23andMe, the personal genetics company backed by Facebook billionaire ...
New app will let doctors review patients’ genome for cancer treatment
Patrick Soon-Shiong, the richest doctor in the world, and Blackberry Chief Executive John Chen made some news at Thursday’s Forbes ...
‘Miracle’ drug grows young girls limbs, costs of rare disease treatments pose challenges
Evie Elsaesser is 5 years old and she loves to run. And that is a medical miracle. When Evie was born, ...
FDA to regulate genetic diagnostic tests, will affect cancer testing
The Food and Drug Administration unveiled plans to regulate thousands of diagnostic tests, including many coming from the exploding field ...
Market for DNA-sequencing-based Down Syndrome tests could top $6 billion
On Wednesday night the New England Journal of Medicine published a study showing that a new, DNA-sequencing based blood test ...
Quest Diagnostics challenges Myriad’s monopoly of breast cancer gene tests
Myriad Genetics, whose patents on two cancer-related genes were invalidated by the Supreme Court in June, could face a strong ...
No, this is not how the human face might look in 100,000 years
One artist’s vision of what humanity will look like in 100,000 years includes huge eyes and foreheads. Apparently, we’re all ...
This protein could change biotech forever
The following is an edited excerpt. A tiny molecular machine used by bacteria to kill attacking viruses could change the ...
David Cox, genomics pioneer emblematic of Pfizer’s new era, dies unexpectedly
The following is an excerpt. David Cox, a geneticist and senior vice president at Pfizer, has died unexpectedly, the company ...
DNA sequencing: Is science fiction becoming medical fact?
In two papers in major scientific journals, researchers today suggested pushing DNA sequencing into more routine use in the clinic, ...
